[Tuberculosis prevention needs adaptation to conditions of Central European countries]

Problemy Tuberkuleza
|January 1, 1993
PubMed

Insights

Stopping mandatory BCG vaccination in low-tuberculosis regions is recommended. The analysis suggests vaccinating older children may be more cost-effective due to low infection risks and vaccination side effects.

Area of Science:

  • Pediatrics
  • Epidemiology
  • Public Health

Context:

  • Mandatory BCG vaccination policies are being re-evaluated in regions with favorable tuberculosis (TB) epidemiology.
  • In Czechia, 160,000 children remain unvaccinated.
  • The annual risk of tuberculous infection in unvaccinated children aged 0-6 years is low, at 0.05%.

Purpose:

  • To analyze the cost-effectiveness of neonatal BCG vaccination in a low-incidence setting.
  • To evaluate the transition rate from tuberculous infection to disease in children.
  • To determine optimal vaccination strategies considering epidemiological data and adverse effects.

Summary:

  • A cost-effectiveness analysis of BCG vaccination initiated in 1986 indicated that vaccination prevented 1 death per 100,000 vaccinated newborns.
  • The transition rate from infection to disease over a 6-year period was 15-20%.
  • Adverse effects of BCG vaccination were noted, and the overall cost of vaccination exceeded the cost of prevented tuberculosis deaths.

Impact:

  • Findings suggest that reconsidering neonatal BCG vaccination and potentially vaccinating older children may be a more appropriate strategy in specific epidemiological contexts.
  • This study informs public health policy regarding childhood vaccination programs for tuberculosis.
  • The research highlights the importance of ongoing evaluation of vaccination efficacy and cost-benefit in relation to disease prevalence.

Related Concept Videos

Transmission-based Precautions II: Airborne and Protective Environment01:25

Transmission-based Precautions II: Airborne and Protective Environment

Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Tuberculosis01:23

Tuberculosis

Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...